LARVOL Onco Data Podcast

Dr. MONIKA LAMBA SAINI joins Dr. Mark Gramling for a broader discussion beyond the usual trial-focused topics in this episode. This time, they explore the world of pathology and the latest technological advancements.Key points include:• The clinical applications of technology in pathology, where Dr. Monika shares insights from her experience in both molecular and digital pathology.• How AI is playing a role in diagnostic applications and how pathologists work and improve patient outcomes.Dr. Monika Lamba Saini, MBBS, MD, Ph.D., is the ‘Global Translational Pathology leader’ at ADC Therapeutics, where she is responsible for the scientific strategy, including the development and implementation of translational tissue-based biomarkers and using digital pathology as a tool to expedite the development pipeline. She previously served as the Director of Digital Pathology Innovation at Q2 Solutions, IQVIA, Edinburgh, where she provided stewardship of digital pathology from validation to implementation of the digital pathology systems, as well as providing pathology support for AI-based algorithms and digital image analyses. She is a pathologist-scientist with 20+ years of experience and proficiency in pathology. She comes with extensive experience in oncopathology, molecular pathology, and digital pathology with her PhD at the Université catholique de Louvain, Brussels, Belgium. She has been the principal investigator and sub-investigator of clinical trials for companion diagnostics in oncology with Cell Carta Belgium. Her experience spans across different countries and continents. She is the author and reviewer of many publications, including Lancet and Nature, and an invited speaker on international platforms. Professional interests include translational research, cancer biology, immunopathology, digital pathology, project design and management, medical writing/publications and public speaking.Tune in to hear how these developments are shaping the future of pathology and clinical diagnostics.

In this episode of the LARVOL Onco Data Podcast, Bruno Larvol and Dr. Mark Gramling dive into key findings from ASTRO 2024. They explore some of the top insights presented at the conference, analyzing their impact and the reaction across social media and within the oncology community. Listeners will also learn how LARVOL CLIN offers insights through data analytics and social media response tracking for conferences like ASTRO. If you're involved in oncology research or pharma, this episode is packed with ways to make the most of conference data and highlights how you can explore these tools for your next event.

🎙️ LARVOL Onco Data Podcast with Dr. Kevin Punie In this episode of the LARVOL Onco Data Podcast, Dr. Kevin Punie joins host Dr. Mark Gramling to discuss the latest insights from ESMO, focusing on key abstracts and social media reactions from the oncology community. Together, they explore critical updates in oncology, including a deep dive into triple-negative breast cancer and how new data is shaping clinical practices. Tune in for an engaging conversation that highlights the role of social media in driving oncology discourse and the future of cancer treatment. For more conference insights and data, visit clint.larvol.com and access real-time updates. #LARVOLPodcast #Oncology #ESMO2024 #CancerResearch #Oncology

Post-ESMO - European Society for Medical Oncology Insights with Christian Hayden from Opus Strategy, LLC and Mark Gramling In this episode of the LARVOL Onco Data Podcast, Mark Gramling teams up with Christian Hayden from Opus Strategy to deliver rapid-fire insights following the ESMO conference. They dive into the outcomes of the Tevosa trial, discussing how, despite some disappointing results, the trial addressed critical research questions that will guide future oncological treatments. Christian and Mark also explore the role of clinical research in shaping oncology care and how findings like these influence oncologists’ decisions worldwide. The conversation balances analysis with a lighthearted wrap-up, reflecting on the importance of transparency in clinical trials. Tune in for takeaways from ESMO and beyond, and catch up on how Opus Strategy and LARVOL are navigating the evolving oncology landscape!#ONCOLOGY #LARVOL #ESMO

Join us for an episode of the LARVOL Onco Data Podcast where Mark Gramling, VP of Oncology at LARVOL, hosts Christian Hayden from Opus Strategy for a Post-World Lung Cancer Conference (WCLC) analysis. Mark and Christian dive into key discussions surrounding emerging oncology targets and reflect on the recent Tropion trial’s ups and downs. They provide valuable insights into the latest data, exploring the landscape of new targets and therapies in different markets and geographies. 💡 Key Topics Discussed: • Reflections on the Tropion trial and its implications in oncology • Analyzing new targets and their impact across various geographies Don’t miss this conversation about the nuances of oncology data and strategy. For more on strategic consulting in the pharma space, reach out to Christian Hayden at Opus Strategy. For oncology data support, LARVOL is here to assist. #Oncology #LARVOL #WCLC #ClinicalTrials

In this engaging episode of the LARVOL Onco Data Podcast, Guru Sonpavde, MD, and Dr. Amol Akhade delve into key takeaways from the latest oncology discussions at ESMO24. The conversation highlights the expanding treatment options for physicians. Our VP of Oncology, Dr. Mark Gramling, emphasized the importance of focusing on the optimal sequencing of treatments like Ambassador, Niagara, EV-302, and Litespark. While more study is needed to determine the best approach, having these additional options is a win for patient care. Dr. Guru shares his thoughts on these important trials and how they have shaped recent discussions in GU cancer research. Dr. Amol adds his perspective on the significance of these trials and the need for continued research. As the episode wraps up, both experts emphasize the value of ongoing collaboration and research, promising more in-depth discussions in the future. Don’t miss out on this lively exchange of insights into the latest advancements in urologic oncology! Check out clin.larvol.com for more oncology data, and don’t forget to follow Dr. Guru and Dr. Amol on social media for updates on future trials. #ESMO24 #GUOncology #AmbassadorTrial #NiagaraTrial #EV302 #Litespark #Oncology #LARVOL

LARVOL ONCO DATA Podcast with Mark Gramling Join Mark Gramling, VP of Oncology at LARVOL, for a solo exploration into the latest developments and insights from the world of oncology data. 🔍 Exploring LARVOL CLIN’s Impact: Dive into how LARVOL CLIN leverages social media reactions and data analytics to provide real-time insights post-ASCO and a preview of upcoming data from EHA. 💡 Social Media Insights: Discover the buzz and reactions surrounding key oncology trials and research. 📊 Preview of ASCO Extracted Data: Get a sneak peek into the data extracted from ASCO and its implications for future oncology research and clinical practice. Stay updated on the latest advancements in oncology. Tune in to the LARVOL ONCO DATA Podcast for an informative session with Mark Gramling. #ASCO24 #EHA2024 #LARVOL #CLIN

Join Dr. Wafik S. El-Deiry, and Dr. Mark Gramling as they discuss the potential of immune response in future cancer treatments and the challenge of managing rapidly evolving oncology data. They explore how clinicians navigate new genetic insights and the continuous progress in cancer research. 🔍 Highlights: • Future potential of immune-based cancer cures • Navigating the ever-growing landscape of oncology data Listen in for insights on the evolving challenges and opportunities in oncology. #Oncology #CancerResearch #LARVOL

LARVOL ONCO DATA Podcast: AI and Outcomes Predictions with Mark Gramling In this solo episode, Mark Gramling dives into the role of AI in predicting outcomes within oncology. Mark discusses how AI technologies are being leveraged to forecast clinical outcomes and improve patient care. Additionally, he highlights upcoming events where these advancements will be showcased. 🔍 What to Expect: • Insights into the latest AI advancements and their practical applications in clinical practice • An overview of upcoming events where these AI-driven innovations will be featured Join us to explore what to look forward to in the upcoming events.

LARVOL ONCO DATA Podcast: Exploring LARVOL Clin with Mark Gramling Join us as Shaheer Shaikh hosts Mark Gramling in a discussion on the latest developments with LARVOL Clin. In this episode, Mark introduces LARVOL Clin, shares exciting upcoming coverage, and highlights the newest updates that are enhancing the platform’s impact on oncology research and clinical decision-making. 🔍 Key Discussion Points: An overview of LARVOL Clin and its role in advancing oncology research. Upcoming coverage and events to keep an eye on for the latest in oncology insights. New updates and features that are making LARVOL Clin even more valuable for users. Don’t miss out on this opportunity to learn how LARVOL Clin can enhance your work in oncology. Tune in to stay informed and ahead of the curve. #Oncology #CancerResearch #LARVOLPodcast #DataAnalytics #ClinicalTrials

LARVOL ONCO DATA Podcast: Collaborative Innovations in Oncology with Opus Strategy, LLC Join us for an episode of the LARVOL ONCO DATA Podcast, hosted by Mark Gramling, featuring Laura Farmer, President of Opus Strategy, and Shabaz Khan, Consultant at Opus Strategy. LARVOL and Opus share a close partnership, often working together to advance oncology research. In this episode, we explore projects that are transforming oncology: 🔍 Collaborative Innovation: LARVOL & Opus Strategy Discover how the partnership between LARVOL and Opus Strategy drives innovation in oncology. Learn about joint projects and shared expertise that enhance data-driven decision-making in cancer research. 💡 Spotlight on Data Integration and AI Explore the HINT model from Georgia Tech and its role in understanding complex biological relationships through multi-modal data integration. Gain insights into InSilico Medicine’s InClinico platform and its use of AI to predict clinical trial success rates. This episode highlights the synergistic efforts of LARVOL and Opus Strategy to push the boundaries of oncology research. Tune in to hear Laura and Shabaz share their expertise and insights on these innovative approaches. #Oncology #CancerResearch #LARVOLPodcast #DataAnalytics #LARVOL #OPUS

Join us for another of the LARVOL ONCO DATA Podcast, where host Mark Gramling is joined by guest Darko Medin, an expert in AI and machine learning applications in oncology. AI in Oncology: Darko Medin shares his insights on how these advanced technologies are revolutionizing oncology data analysis. Innovative Applications: Learn about the latest innovations in AI and how they are being utilized to improve accuracy, planning, and patient outcomes in oncology. Real-World Implications: Gain valuable perspectives on the real-world implications of integrating AI in oncology. Tune in to the LARVOL ONCO DATA Podcast.

Deep Dive: Post-EHA 2024 Analysis | Join us for a special podcast featuring LARVOL's Mark Gramling in conversation with Christian Hayden, Director at Opus Strategy, LLC, as they take a deep dive into the recent European Hematology Association (EHA) conference. 🔍 EHA Insights: Gain insights into the key takeaways and groundbreaking research presented at EHA. Christian Hayden and Mark Gramling will explore the most significant advancements and their potential impact on hematology. 💡 Analysis: Christian Hayden brings his strategic expertise to the discussion, providing analysis and perspectives on the trends and developments in hematology research. 🌐 Implications for Practice: Discover how the findings from EHA can be translated into clinical practice. 📊 Future Directions: Learn about the emerging therapies and innovative approaches highlighted at EHA. Don’t miss this episode as we delve into the key highlights from EHA with industry experts. Tune in to stay updated on the latest advancements with the LARVOL Onco Data Podcast. #LARVOL #Oncology #CancerResearch #MedicalOncology #CancerTreatment #CancerCare #OncologyUpdates #HealthcareInnovation #MedicalPodcast #EHA2024

Join hosts Mark Gramling and special guest Dr. Guru Sonpavde, MD, for an insightful episode of the LARVOL ONCO DATA Podcast, focusing on the latest advancements and research in bladder cancer. 🔍 Bladder Cancer Insights: Dr. Sonpavde, a leading expert in oncology, shares his knowledge on the current trends and future directions in bladder cancer research and treatment. 💡 LARVOL CLIN in Action: Discover how the LARVOL CLIN platform is being leveraged to provide real-time analytics and insights into bladder cancer, enhancing the understanding and management of this complex disease. 🌐 Innovative Approaches: Explore cutting-edge technologies and methodologies being applied in bladder cancer research, from novel therapies to data-driven strategies that are shaping the future of oncology. 📊 Expert Perspectives: Gain valuable insights from Dr. Sonpavde and Mark Gramling as they discuss the implications of recent studies, clinical trials, and the role of LARVOL CLIN in advancing bladder cancer care. Tune in to the LARVOL ONCO DATA Podcast for an informative discussion on bladder cancer. #LARVOL #OncoDataPodcast #Oncology #CancerResearch #MedicalOncology #CancerTreatment #CancerCare #OncologyUpdates #HealthcareInnovation #MedicalPodcast #BladderCancer #CheckMate901 #EV302

LARVOL ONCO DATA Podcast: Insights with Bruno Larvol and Arturo LoAIza-Bonilla MD Join Bruno Larvol for an episode of the LARVOL ONCO DATA Podcast featuring Dr. Arturo LoAlza-Bonilla, Co-Founder of Massive Bio and Medical Director of Oncology Research at Capital Health. 🔍 Dr. LoAlza-Bonilla shares his expertise on the latest oncology research and treatment advancements. 💡 Innovative Approaches: Explore the methodologies used in oncology today, including the impact of AI and data-driven analytics on patient care and research. 🌐 Collaborative Efforts: Learn about the importance of collaboration in oncology, as Dr. LoAlza-Bonilla highlights how multidisciplinary efforts are driving progress in cancer care. Don’t miss this opportunity to gain valuable insights. Tune in to the LARVOL ONCO DATA Podcast for an informative discussion hosted by Bruno Larvol.

LARVOL Onco Data Podcast: ASCO Insights with Dr. Kai-Keen Shiu and Mark Gramling Join us for an episode of the LARVOL Onco Data Podcast, where host Mark Gramling and guest Dr. Kai-Keen Shiu delve into the insights from the American Society of Clinical Oncology (ASCO). This episode will focus on the impact and applications of the LARVOL CLIN Platform in interpreting and utilizing ASCO data. 🔍 ASCO Insights: Uncover key takeaways from the recent ASCO meeting, as Dr. Shiu and Mark Gramling discuss the research and emerging trends in oncology. 💡 LARVOL CLIN Platform: Explore how LARVOL CLIN enhances understanding and application of complex ASCO data. Learn how this platform provides real-time analytics and expert insights that help oncology professionals make informed decisions. 🌐 Navigating Cancer Research: Gain a deeper understanding of how ASCO's findings are integrated into current oncology practices and future research directions, focusing on the practical applications made possible by LARVOL CLIN. Don't miss this opportunity to hear expert analysis of ASCO's influential research and how technologies like LARVOL CLIN are shaping the field of oncology.

LARVOL ONCO DATA Podcast: Post-ASCO Insights with Mark Gramling and Bruno Larvol Join hosts Mark Gramling and Bruno Larvol for an episode of the LARVOL Onco Data Podcast as we go through the latest insights and discoveries from the recent ASCO conference. 🔍 Exploring ASCO Highlights: Highlighting key takeaways from ASCO as we analyze the most significant advancements, trials, and presentations in oncology. 💡 Analysis: Gain insights as we discuss the latest research findings. 📊 Data-driven Discussions: Join us for a data-driven discussion for navigating the landscape of oncology research and development. Don’t miss the latest post-ASCO insights. Tune in to the LARVOL Onco Data Podcast for a thought-provoking discussion.

🎙️ LARVOL ONCO DATA Podcast: ASCO 2024 Insights Join hosts Mark Gramling and Bruno Larvol for another episode of the LARVOL ONCO DATA Podcast, where we follow the latest trends and insights shaping the oncology landscape. Exploring Social Media Reactions: Get access to the latest social media reactions from top oncologists on LARVOL CLIN. Discover the buzz surrounding groundbreaking trials, including HARMONi, LAURA, and ADRIATIC, as we analyze the implications and reactions from the oncology community. Engage with Industry Leaders: Connect with us live at ASCO and learn more about LARVOL CLIN. Engage with industry leaders, explore new opportunities, and gain valuable insights that will shape the future of oncology research and treatment. Stay informed and connected with the latest developments in oncology.

🎙️ LARVOL ONCO DATA Podcast: Preparing for ASCO with Data Analytics, Social Media Reactions, & Conference Planning Join Mark Gramling and Bruno Larvol for another episode of LARVOL ONCO DATA Podcast as they gear up for the upcoming ASCO conference. This pre-ASCO episode will focus on the essential aspects of data analytics, social media reactions, and conference planning. 🌐 Exploring ASCO Preparations: Gain insights into the latest preparations and expectations for the upcoming ASCO conference, including strategies for effective data analytics, monitoring social media reactions, and comprehensive conference planning. 💡 Data Analytics Insights: Discover how data analytics are shaping the landscape of oncology research and how they can be leveraged to enhance your experience and insights at ASCO. 🔍 Social Media Reactions: Explore the significance of social media reactions in the context of oncology conferences like ASCO, and learn how to effectively monitor and engage with online discussions. 📅 Conference Planning Strategies: Get valuable tips and strategies for effective conference planning, ensuring that you make the most out of your ASCO experience. Tune in to the LARVOL ONCO DATA Podcast for insights and practical tips.

🎙️ LARVOL ONCO DATA Podcast: AACR Insights with Mark Gramling, Judith Perez, and Erin Olsen from Bluestarbio Advisors Join us for an episode of LARVOL ONCO DATA Podcast as we unpack the latest developments from the American Association for Cancer Research (AACR) conference. Our hosts, Mark Gramling and Judith Perez from LARVOL, along with Erin from Bluestarbio Advisors, share their perspectives and insights. 🌐 Reflecting on AACR: Dive into the highlights and key takeaways from AACR, one of the most significant events in the field of cancer research. 💡 Expert Analysis: Gain valuable insights from our panelists as they analyze the latest research findings, trends, and advancements presented at AACR. 🔍 Real-World Applications: Discover how these insights from AACR are shaping the future of oncology research and clinical practice, with a focus on practical applications and implications. Join us for an episode that delves into the post-AACR landscape. Tune in to LARVOL ONCO DATA Podcast for an engaging discussion. Checkout Bluestarbio Advisor on this link: https://lnkd.in/gBz-pMKb